Lin Lin

US Patent:

7191136, Mar 13, 2007

Filed:

Oct 1, 2002

Appl. No.:

10/261454

Inventors:

Deepen Sinha - Chatham NJ, US
Masoud Alghoniemy - Alexandria, EG
Lin Lin - Bridgewater NJ, US
Alex Cabanilla - Middlesex NJ, US

Assignee:

iBiquity Digital Corporation - Warren NJ

International Classification:

G10L 19/00

US Classification:

704500, 704205, 704501

Abstract:

An efficient coding scheme with higher audio bandwidth and/or better audio quality at lower bitrates, wherein the scheme eliminates long-term and short-term frequency domain correlation in a signal via frequency domain predictors. The coding scheme compresses information consisting of coded low frequency components as well as a parametric representation for the high frequency components based on a non-linear model. Additionally, by working on the frequency domain representations of the signal (such as the MDCT representation which is naturally available to a PAC encoder and decoder), low pass and high pass signal components are easily obtained by windowing the appropriate ranges of frequencies in the signal. Furthermore, the power functions of the signal are replaced by corresponding convolution functions of the same order.

US Patent:

7952474, May 31, 2011

Filed:

Mar 15, 2005

Appl. No.:

11/885814

Inventors:

Pengju Kang - Yorktown Heights NY, US
Alan M. Finn - Hebron CT, US
Robert N. Tomastik - Rocky Hill CT, US
Thomas M. Gillis - Manchester CT, US
Ziyou Xiong - West Hartford CT, US
Lin Lin - Manchester CT, US
Pei-Yuan Peng - Ellington CT, US

Assignee:

Chubb Protection Corporation - Farmington CT

International Classification:

G08B 19/00

US Classification:

340522, 340521, 340506, 340507, 340508, 340552, 340554, 340561, 340567

Abstract:

An alarm filter () for use in a security system () to reduce the occurrence of nuisance alarms receives sensor signals (S-S, S) from a plurality of sensors () included in the security system (). The alarm filter () produces an opinion output as a function of the sensor signals and selectively modifies the sensor signals as a function of the opinion output to produce verified sensor signals (S′-S′).

US Patent:

20120301474, Nov 29, 2012

Filed:

May 11, 2012

Appl. No.:

13/470177

Inventors:

Brad J. Spellberg - Rancho Palos Verdes CA, US
Lin Lin - Rancho Palos Verdes CA, US
Ashraf Ibrahim - Irvine CA, US
Guanpingsheng Luo - Torrance CA, US

Assignee:

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center - Torrance CA

International Classification:

A61K 39/02
C07K 7/08
C07K 7/06
C07K 5/08
A61P 37/04
C12N 15/63
C07K 16/12
A61K 39/395
A61P 31/04
C07K 14/21
C12N 15/31

US Classification:

4241391, 4242341, 530350, 530326, 530329, 530327, 530324, 530331, 4241901, 536 237, 4353201, 5303879

Abstract:

The present invention provides vaccine compositions comprising OmpA, or antigenic fragments thereof, and related methods of active immunization against infection. The invention also provides antibodies and antigen-binding parts thereof that specifically bind to OmpA, and related methods of passive immunization against infection. The compositions and methods of the invention are useful for preventing or treating infections, including those caused by strains resistant to carbapenems and all other antibiotics except colistin or tigecycline, also referred to as extreme drug resistant (XDR) infections, and those resistant to every FDA approved antibiotic, also referred to as pan-drug resistant (PDR) infections.

US Patent:

20130202616, Aug 8, 2013

Filed:

Jan 24, 2013

Appl. No.:

13/749499

Inventors:

Brad J. Spellberg - Rancho Palos Verdes CA, US
Lin Lin - Rancho Palos Verdes CA, US

Assignee:

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center - Torrance CA

International Classification:

C12N 9/86
C07K 16/40

US Classification:

4241581, 4242341, 4241781, 5303917, 4242591

Abstract:

The present invention provides vaccine and pharmaceutical compositions for treating or preventing bacterial inventions. The vaccine compositions of the invention include a carbapenemase such as a serine carbapenemase, a metallo-β-lactamase or an immunogenic fragment thereof. The pharmaceutical compositions include an anti-carbapenemase antibody or fragment thereof. Also provided are methods for treating and preventing a bacterial infection using the vaccine and pharmaceutical compositions of the invention. The invention further provides antibody conjugates that include an antibody or fragment thereof conjugated to a siderophore or an analog thereof.

US Patent:

20130310307, Nov 21, 2013

Filed:

Mar 13, 2013

Appl. No.:

13/801324

Inventors:

Lin LIN - Rancho Palos Verdes CA, US

Assignee:

LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER - TORRANCE CA

International Classification:

A61K 38/17

US Classification:

514 27, 514 23, 514 28, 514 33, 514 31, 514 34

Abstract:

The invention provides a method of killing an infectious microbe by administering an effective amount of transferrin to an individual having a microbial infection, wherein the transferrin has microbicidal activity, thereby reducing survival of the infectious microbe in the individual. The invention also provides a method of prophylactically treating an individual to decrease the likelihood of contracting a microbial infection, comprising administering an effective amount of transferrin to an individual, wherein the transferrin has microbicidal activity, thereby decreasing the likelihood that the individual will contract a microbial infection. The invention still further provides a method of treating septicemia by administering an effective amount of transferrin to an individual in need thereof, thereby treating the individual.

US Patent:

60722843, Jun 6, 2000

Filed:

Jul 20, 1998

Appl. No.:

9/118974

Inventors:

Lin Lin - Clifton NJ

Assignee:

Duro-Test Corporation - Bloomfield NJ

International Classification:

G05F 100

US Classification:

315307

Abstract:

A compact fluorescent lamp and an electronic ballast therefor are mounted on a three-terminal base which can be fitted into a three-way-switched standard AC lamp socket, so as to be responsive to the three powered switch positions of the socket for generating three light output levels. The ballast includes an AC-to-DC conversion circuit which supplies a lamp driver including a DC-to-AC conversion circuit, an oscillatory circuit and a resonant circuit. In one embodiment the AC-to-DC conversion circuit includes a full bridge rectifier and a voltage doubler producing two operating voltage levels for the lamp driver and two frequency control voltage levels for the oscillator, the ballast generating three light output levels by using two operating voltages and two operating frequencies. One of the lamp filaments is connected in series with the supply circuit for the oscillator so that the oscillator is inoperative when the lamp is disconnected or its filament burns out, and there is a feedback circuit from the resonant circuit to the oscillator supply for stabilizing its operating frequency. In another embodiment the AC-to-DC conversion circuit includes a half bridge rectifier and two voltage doublers for producing three operating voltages for the lamp driver to generate the three light output levels.

US Patent:

20200247715, Aug 6, 2020

Filed:

Sep 27, 2018

Appl. No.:

16/651850

Inventors:

- Corning NY, US
Guangli Hu - Berkeley Heights NJ, US
William Joseph Hurley - Corning NY, US
Dana Ianson - Westfield PA, US
Lin Lin - Painted Post NY, US
Santona Pal - Corning NY, US
James Joseph Price - Corning NY, US

International Classification:

C03C 17/245
C03C 17/22
C03C 3/091
C03C 3/097

Abstract:

An article that includes: a substrate having a glass, glass-ceramic or a ceramic composition and comprising a primary surface; and a protective film disposed on the primary surface. The protective film comprises a thickness of greater than 1.5 microns and a maximum hardness of greater than 15 GPa at a depth of 500 nanometers, as measured on the film disposed on the substrate. Further, the protective film comprises a metal oxynitride that is graded such that an oxygen concentration in the film varies by 1.3 or more atomic %. In addition, the substrate comprises an elastic modulus less than an elastic modulus of the film.

US Patent:

20150079116, Mar 19, 2015

Filed:

Apr 11, 2013

Appl. No.:

14/391814

Inventors:

- Oakland CA, US
Lin Lin - Los Angeles CA, US

International Classification:

C12Q 1/68
G01N 33/68

US Classification:

4241831, 506 9, 51426337, 514352, 514567, 514169, 5142632, 5142633, 514249, 514 205, 514291, 506 16, 514398, 51425308, 506 18

Abstract:

NK cell licensing predisposes patients to chronic inflammatory disease. Methods and kits to diagnose and treat chronic inflammatory disease based on genetic haplotype and cytokine profile are described herein.